2LHERP®

DRUG2 trials

Sponsors

Labo'Life

Conditions

Herpes SimplexHerpes Simplex, Genital

Phase 4

Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections.

RecruitingNCT04065971

Labo'LifeHerpes Simplex

Start: 2020-03-10End: 2027-03-31Target: 140Updated: 2026-08-27

Study of 2LHERP® in Genital Herpes Infections

TerminatedNCT04235322

Labo'LifeHerpes Simplex, Genital

Start: 2021-01-25End: 2023-04-18Updated: 2023-10-10